Moreover, a recent study reported genetic knockdown of TXN leads to accumulation of lipid ROS levels and induces an antioxidant response to cause ferroptosis, a potential pro‐ferroptotic agent due to its inhibition of TXN would be an anti‐cancer therapeutic strategy.29 Here, TXN is linked to cancer.